Imatinib meta-methyl-piperazine impurity
CAS: 1246819-59-9
Ref. 3D-WZB81959
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued |
Product Information
Name:
Imatinib meta-methyl-piperazine impurity
Description:
Imatinib is a drug product that has been shown to have significant anticancer activity in the treatment of chronic myeloid leukemia and some other cancers, including gastrointestinal stromal tumor. Imatinib is an orally active tyrosine kinase inhibitor with a half-life of 5-6 hours. It is metabolized to a methyl-piperazine impurity, which is identified as an analytical standard for HPLC analysis. The impurity has been shown to be naturally occurring and also results from metabolism studies in rats and humans. Imatinib is not included in the pharmacopoeia because it has not yet been approved for use in any country.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
493.6 g/mol
Formula:
C29H31N7O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
